Replies to post #67641 on NanoViricides Inc. (NNVC)

[Puffer]

And people are voting with their wallet. That's why this stock stays in the 50s and 60s.

Actually the $93M market cap that that price represents is about right for a company more than a year out from clinical trials. Look at CTIX for example... currently IN clinical trials and a market cap of only $153M. The price will likely rise as we get reports on tox, the cGMP facility nears completion, and a clinical trial date is set.